Grants and Contributions:
Title:
Evaluation of a bone-promoting agent in local and systemic administration models.
Agreement Number:
911801
Agreement Value:
$50,000.00
Agreement Date:
Aug 1, 2018 - Mar 15, 2019
Description:
To support upcoming IND filings the firm’s lead candidate bone growth promoting drug will be tested for efficacy in animal (rodent) models, one requiring systemic administration and the other requiring local administration.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2018-2019-Q2-911801
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
832032031
Recipient Type:
For-profit organization
Recipient's Legal Name:
Mesentech Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171